• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    PURPOSE: To provide an ultraviolet absorber or a light stabilizer exhibiting excellent absorbing performances over a wide range of ultraviolet wavelengths and having high stability and high safety, and to provide an ultraviolet absorbing composition, a light-stabilizing composition and a skin care preparation for external applications comprising the same. CONSTITUTION: The ultraviolet absorber and the light stabilizer each comprise as an effective ingredient a pyridazine derivative of the general formula £wherein R1, R2, R3 and R4 are not simultaneously a hydrogen atom; and R2 and R3 are not simultaneously a morpholino group| and/or a salt thereof. The ultraviolet-absorbing composition, the light-stabilizing composition and the skin care preparation for external applications each comprise the same.
    公开号:KR20020096931A
    申请号:KR1020020033475
    申请日:2002-06-15
    公开日:2002-12-31
    发明作者:수에츠구카츠；하라에이지로
    申请人:가부시키가이샤 시세이도；
    IPC主号:
    专利说明:

    UV absorbers, light stabilizers and UV absorbent compositions, light stabilizer compositions, and skin external preparations containing the same
    [10] TECHNICAL FIELD The present invention relates to an ultraviolet absorbent, a light stabilizer, an ultraviolet absorbent composition containing the same, a light stabilizer composition, a skin external preparation, and in particular, its stability and usability improvement.
    [11] Of the ultraviolet rays contained in the sunlight, ultraviolet rays having a wavelength of 290 nm or less are absorbed by the ozone layer and do not reach the surface, but ultraviolet rays of 290 nm to 400 nm reach the surface and have various effects. Dermatologically, it is known that medium wavelength ultraviolet rays of 290 nm to 320 nm cause erythema and blister formation, melanin formation, pigmentation, and the like. In addition, the long wavelength ultraviolet rays of 320 nm to 400 nm have an immediate blackening effect of blackening the skin immediately after irradiation, and the energy reaches the dermis, thus affecting the elastic fibers in the blood vessel wall or connective tissue. The action of such medium to long wavelength ultraviolet rays is thought to be the cause of aging of the skin and the formation of spots, freckles, wrinkles and the like.
    [12] In order to protect skin from such ultraviolet rays, ultraviolet absorbers such as benzotriazole derivatives, benzophenone derivatives, salicylic acid derivatives, paraamino benzoic acid derivatives, cinnamic acid derivatives and urokanoic acid derivatives have been used.
    [13] These ultraviolet absorbers are also used as light stabilizers, such as pigment | dye, fragrance | flavor, and a chemical agent mix | blended with a pharmaceutical and cosmetics.
    [14] UV absorbers are also used in fields other than pharmaceuticals and cosmetics. For example, UV absorbers are added or coated to various materials such as paints, dyes, pigments, various resins, synthetic rubbers, latexes, films, fibers, and glass to impart ultraviolet absorbing ability. In addition, the product itself or a product coated with the coating film or film thereof is used to protect the product from ultraviolet rays, to prevent deterioration and alteration caused by ultraviolet rays, and to maintain quality.
    [15] It is preferable that a ultraviolet absorber can absorb the ultraviolet-ray of 290 nm-400 nm which reaches an index over all wavelength ranges. In addition, when the ultraviolet absorbent is blended into the external preparation for skin, it is important not only that the skin is irritant but that the ultraviolet absorbent does not decompose due to sun exposure.
    [16] However, conventional ultraviolet absorbers have not been very satisfactory in these respects. Moreover, conventional ultraviolet absorbers may generate coloring and precipitation when used together with the inorganic powder-type sunscreen agent which is used abundantly in skin external preparations. And as a light stabilizer, what has become more satisfying was calculated | required.
    [17] Moreover, in the conventional ultraviolet absorber of the fields other than a pharmaceutical and cosmetics, there existed a problem that it sublimed by heating and volatilization at the time of plating of a coating film, the shaping | molding of resin, etc., or gradually volatilized with time, without heating, and a low effect.
    [18] This invention is made | formed in view of the said subject of the said prior art, The objective is to provide the ultraviolet absorber and the light stabilizer which have the outstanding absorption ability over a wide ultraviolet wavelength range, and also high stability and safety. Another one is to provide an ultraviolet absorbent composition and a light stabilizer composition in which the ultraviolet absorbent and the light stabilizer are blended. Another object is to provide an external skin preparation containing this ultraviolet absorber and a light stabilizer.
    [1] 1 is a diagram showing an ultraviolet absorption spectrum of a pyridazine derivative, 4,5-dipiperidino-3-hydroxypyridazine of the present invention,
    [2] Fig. 2 is a diagram showing the ultraviolet absorption spectrum of the pyridazine derivative, 3-hydroxy-4-piperidinopyridazine of the present invention,
    [3] Fig. 3 is a diagram showing the ultraviolet absorption spectrum of the pyridazine derivative, 3-hydroxy-5-piperidinopyridazine of the present invention,
    [4] 4 is a diagram showing the ultraviolet absorption spectrum of the pyridazine derivative, 3-hydroxy-4-morpholinopyridazine of the present invention,
    [5] Fig. 5 is a diagram showing the ultraviolet absorption spectrum of the pyridazine derivative, 3-hydroxy-5-morpholinopyridazine of the present invention,
    [6] 6 is a diagram showing an ultraviolet absorption spectrum of a pyridazine derivative of the present invention, 5-bis (2-hydroxyethyl) amino-3-hydroxypyridazine,
    [7] 7 is a diagram showing the ultraviolet absorption spectrum of the pyridazine derivative, 3-hydroxy-6-morpholinopyridazine of the present invention,
    [8] Fig. 8 is a diagram showing the ultraviolet absorption spectrum of the pyridazine derivative, 3,6-bis (2-hydroxyethylamino) pyridazine of the present invention,
    [9] Fig. 9 shows the ultraviolet absorption spectrum of the pyridazine derivative of the present invention, 3,6-dimorpholinopyridazine.
    [19] In order to achieve the above object, the present inventors earnestly examined, and as a result, to find out which kind of pyridazine derivatives have the above properties and are excellent as ultraviolet absorbers and light stabilizers, Reached.
    [20] That is, the ultraviolet absorbent and the light stabilizer of the present invention are characterized by having the following pyridazine derivatives and salts thereof having excellent absorption ability over a wide ultraviolet wavelength range and high stability and safety thereof as active ingredients.
    [21]
    [22] [Wherein, R 1 and R 4 are each independently a hydrogen atom, a hydroxyl group, a lower alkyl group, a lower alkoxy group, or a N (R 5 ) R 6 group [R 5 and R 6 are the same or different, and a hydrogen atom, a lower alkyl group, A lower hydroxyalkyl group or R 5 and R 6 together form an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidino group, a hexahydroazinyl group, a heptamethylene imino group, an octamethylene imino group together with a nitrogen atom, A heterocyclic group selected from the group consisting of a morpholino group, a thiomorpholino group, a piperadinyl group, and a 4-lower alkylpiperadinyl group]. A hydroxyl group, a lower alkyl group, a lower alkoxy group, or an N (R 7 ) R 8 group [R 7 and R 8 are the same or different and are a hydrogen atom, a lower alkyl group, a lower hydroxyalkyl group or R 7 and R 8 together With aziridinyl, azetidinyl, blood A complex selected from the group consisting of a lidinyl group, a piperidino group, a hexahydroazinyl group, a heptamethyleneimino group, an octamethylene imino group, a morpholino group, a thiomorpholino group, a piperadinyl group, and a 4-lower alkylpiperadinyl group Indicates ventilation. Provided that R 1 , R 2 , R 3 and R 4 are not hydrogen atoms at the same time, and R 2 and R 3 are not morpholino groups at the same time.]
    [23] The ultraviolet absorbent composition of this invention contains the said ultraviolet absorber, It is characterized by the above-mentioned.
    [24] The light stabilizer composition of this invention contains the said light stabilizer, It is characterized by the above-mentioned.
    [25] Moreover, the external preparation for skin of this invention contains the said ultraviolet absorber, It is characterized by the above-mentioned. In the external preparation for skin of the present invention, it is preferable to further contain an inorganic powder.
    [26] The external preparation for skin of the present invention contains the above-mentioned light stabilizer. In the external preparation for skin of the present invention, it is preferable to further contain a metal ion sequestrant.
    [27] Moreover, in the skin external preparation of this invention, it is preferable that the compounding quantity of the said pyridazine derivative and / or its salt is 0.001-20 mass%.
    [28] The pyridazine derivatives of the present invention can be converted to their mutual variants by equilibrium under certain conditions. In the present invention, only one of them is described for convenience, but the mutual variants or mixtures thereof may be used.
    [29] In the chemical name, the pyridazine derivative of the present invention is 4,5-dipyrrolidinyl-3-hydroxypyridazine, 4,5-dipiperidino-3-hydroxypyridazine, 4,5-dihexahydroazepide Nyl-3-hydroxypyridazine, 4,5-dipyreradinyl-3-hydroxypyridazine, 4,5-bis (4-methylpiperidinyl) -3-hydroxypyridazine, 4,5- Bis (bis (2-hydroxyethyl) amino) -3-hydroxypyridazine, 4,5-bis (tris (hydroxymethyl) methylamino) -3-hydroxypyridazine, 3-hydroxy-4- Pyrrolidinylpyridazine, 3-hydroxy-5-pyrrolidinylpyridazine, 3-hydroxy-4-piperidinopyridazine, 3-hydroxy-5-piperidinopyridazine, 3-hydroxy- 4-morpholinopyridazine, 3-hydroxy-5-morpholinopyridazine, 4-bis (2-hydroxyethyl) amino-3-hydroxypyridazine, 5-bis (2-hydroxyethyl) amino- 3-hydroxypyridazine, 3-hydroxy-4-tris (hydroxymethyl) methylaminopyridazine, 3-hydroxy Ci-5-tris (hydroxymethyl) methylaminopyridazine, 3-hydroxy-6-morpholinopyridazine, 3,6-bis (2-hydroxyethylamino) pyridazine, 3,6-dimorpholino Pyridazine, 4,5-dipyrrolidinyl-3-hydroxypyridazine hydrochloride, 4,5-dipiperidino-3-hydroxypyridazine hydrochloride, 3-hydroxy-5-piperidinopyridazine hydrochloride, 3 -Hydroxy-5-morpholinopyridazine hydrochloride, 5-bis (2-hydroxyethyl) amino-3-hydroxypyridazine hydrochloride, 3-hydroxy-5-tris (hydroxymethyl) methylaminopyridazine hydrochloride , 3-hydroxy-6-morpholinopyridazine hydrochloride, 3,6-bis (2-hydroxyethylamino) pyridazine hydrochloride, 4,5-bis (bis (2-hydroxyethyl) amino) -3- Hydroxypyridazine hydrochloride, 4,5-bis (tris (hydroxymethyl) methylamino) -3-hydroxypyridazine hydrochloride, and the like.
    [30] The pyridazine derivative of the present invention is commercially available from ALDRICH Co., Ltd., SIGMA Co., Ltd., Tokyo Kasei Co., Ltd., etc., can be easily obtained, or can be synthesized by a known method. The typical manufacturing method is shown below.
    [31]
    [32] In the above scheme, A represents a chlorine atom or bromine atom.
    [33] Compound (2) (if A is a chlorine atom; 4,5-dichloro-3-hydroxypyridazine / if A is a bromine atom; 4,5-dibromo-3-hydroxypyridazine) From the available compound (1) (When A is a chlorine atom; Cocololic acid free / A is bromine atom; Cocobromic acid) according to the above scheme, Chemische Berichte, 32 , 543 (1899) and the like It can synthesize | combine easily by it. That is, compound (2) (A is a chlorine atom or a bromine atom) can be easily obtained by ring-closing compound (1) (A is a chlorine atom or a bromine atom) with hydrazine. In addition, compound (2) (A is a chlorine atom) is commercially available from ALDRICH, etc., and can be easily obtained. And the pyridazine derivative of this invention can be obtained by making compound (2) (A is a chlorine atom or a bromine atom) react with amines, such as a piperidine.
    [34] In addition, the pyridazine derivative of this invention can be made into an inorganic acid salt or an organic acid salt by a well-known method. Inorganic acids include hydrochloric acid, sulfuric acid, phosphoric acid, hydrobromic acid, and the like. Examples of the organic acid include acetic acid, lactic acid, maleic acid, fumaric acid, tartaric acid, citric acid, methanesulfonic acid and p-toluenesulfonic acid.
    [35] UV absorbers and external skin preparations
    [36] Although the ultraviolet absorber which has the pyridazine derivative of this invention or its salt as a main component can be mix | blended with various products, it is preferable to mix | blend with the skin external preparation. The external preparation for skin containing the ultraviolet absorbent of the present invention exhibits an excellent ultraviolet protective effect, and the ultraviolet absorbent is not decomposed even under sunlight exposure, and thus the effect is stably exhibited for a long time. Also, skin trouble does not occur. Therefore, it is especially useful as a skin external preparation for sunscreens.
    [37] In addition, in the skin external preparation for sunscreen, in order to enhance the ultraviolet-ray blocking effect, it is preferable to use an inorganic type ultraviolet-ray breaker together with an organic compound type ultraviolet absorber. In addition, inorganic powders are often blended in makeup cosmetics. However, discoloration may occur when an organic gyro-absorber is used in combination with an inorganic powder.
    [38] The ultraviolet absorbent of the present invention does not cause discoloration even when formulated with the external preparation for skin together with the inorganic powder, and therefore can be used in combination with the inorganic powder.
    [39] Inorganic powder
    [40] Such inorganic powder is not particularly limited as long as it is usually formulated into cosmetics and pharmaceuticals. For example, talc, kaolin, boron nitride, mica, mica (cellite), dolomite, biotite, gold mica, synthetic mica, synthetic mica, permicalite, magnesium carbonate, calcium carbonate, silicic anhydride, aluminum silicate, aluminum oxide , Barium silicate, calcium silicate, magnesium silicate, tungstate metal salt, magnesium, silica, zeolite, barium sulfate, calcined calcium sulfate, calcined gypsum, calcium phosphate, fluorite apatite, hydroxyapatite, ceramic powder, metal soap (zinc myristic acid salt) Titanium oxide, zinc oxide, iron oxide, iron titanate, carbon, lower titanium oxide, mango violet, cobalt violet, chromium oxide, chromium hydroxide, cobalt titanate, ultramarine blue, Inorganic preparations such as titanium oxide coated mica, titanium oxide coated oxychloride bismuth chloride, titanium oxide coated talc, colored titanium oxide coated mica, oxychloride bismuth, and young foil A.
    [41] Light stabilizer
    [42] The pyridazine derivatives and salts thereof of the present invention are also useful as light stabilizers. In particular, it is excellent for photo stabilization of pigments, perfumes and pharmaceuticals blended in pharmaceuticals and cosmetics. Moreover, the pyridazine derivative of this invention and its salt can obtain synergistically improved photostabilization effect by combining a metal ion blocking agent.
    [43] Metal Ion Blocker
    [44] Examples of the metal ion sequestrant used in combination with the pyridazine derivatives and salts thereof in the present invention include ethylenediamine tetraacetic acid (EDTA) sodium salt, ethylenediamine hydroxyethyl triacetate, phosphoric acid, citric acid, ascorbic acid, Succinic acid, gluconic acid, sodium polyphosphate, sodium metaphosphate, hydroxyethanediphosphonate, ethidronate, and the like.
    [45] Use of external skin preparations
    [46] The skin external preparation of this invention mix | blends the said ultraviolet absorber or the said light stabilizer. The form of the external preparation for skin of the present invention is not particularly limited as long as the effect of the present invention is exhibited. For example, in addition to skin care cosmetics such as lotion, latex, cream, cosmetic liquid, makeup cosmetics such as foundation, foundation, lipstick, face color, eyeliner, hair spray, hair tonic, hair liquid and the like, Cosmetics for the scalp, perfumes, aromatic cosmetics such as eau de cologne, shampoo, rinse, and the like.
    [47] Compounding amount of pyridazine derivatives and salts thereof in external skin preparations
    [48] When blending the pyridazine derivative of the present invention and the salt thereof with the external preparation for skin, the blending amount may be appropriately determined according to the intended ultraviolet absorbing ability or the light stabilizing ability, but in the composition, preferably 0.001 to 20% by mass, more preferably Is 0.01-10 mass%. When the amount is less than 0.001% by mass, the ultraviolet ray preventing effect or the light stabilizing effect may not be sufficiently obtained, and when the amount is more than 20% by mass, it may be difficult to maintain the formulation.
    [49] Other ingredients
    [50] In the external preparation for skin of the present invention, in addition to the above essential ingredients, ingredients that can be commonly formulated in cosmetics and pharmaceuticals, for example, liquid oils, solid fats, lead, hydrocarbons, higher fatty acids, higher alcohols, esters, silicones, anionic surfactants and cations Surfactants, Amphoteric Surfactants, Nonionic Surfactants, Moisturizers, Water Soluble Polymers, Thickeners, Coatings, Lower Alcohols, Polyhydric Alcohols, Sugars, Amino Acids, Organic Amines, pH Adjusters, Skin Nutrients, Vitamins, Antioxidants , Fragrance, powder, colorant, water and the like can be appropriately blended as necessary. Moreover, ultraviolet absorbers and light stabilizers other than the pyridazine derivative of this invention can also be mix | blended as long as the effect of this invention is impaired.
    [51] UV absorbing composition
    [52] In addition, the ultraviolet absorbent according to the present invention may be blended with products other than the external preparation for skin, for example, paints, dyes, pigments, various resins, synthetic rubbers, latexes, films, fibers, glass, and the like to form ultraviolet absorbent compositions. It is possible to do The pyridazine derivatives according to the present invention are excellent in thermal stability and do not volatilize, and thus their effects can be maintained for a long time. The compounding quantity in this case is preferably 0.001-20 mass%, More preferably, it is 0.01-10 mass%. When it is less than 0.001 mass%, the ultraviolet protective effect may not be enough, and when it is more than 20 mass%, molding etc. may become difficult, and it is unpreferable.
    [53] Light stabilizing composition
    [54] In addition, the light stabilizer according to the present invention may be blended into a product other than an external preparation for skin, such as paints, dyes, pigments, various resins, synthetic rubbers, latexes, films, fibers, glass, and the like for light stabilization compositions. It is possible. The pyridazine derivatives according to the present invention are excellent in thermal stability and do not volatilize, and thus their effects can be maintained for a long time. The compounding quantity in this case is preferably 0.001-20 mass%, More preferably, it is 0.01-10 mass%. If the amount is less than 0.001% by mass, the light stabilization effect may not be sufficient. If the amount is more than 20% by mass, molding may be difficult, and therefore, this is not preferable.
    [55] Hereinafter, the present invention will be described in detail with specific examples. In addition, this invention is not limited to these.
    [56] First, the manufacture example of the pyridazine derivative of this invention is shown.
    [57] Preparation Example 1 4,5-Dipiperidino-3-hydroxypyridazine
    [58] 4,5-dichloro-3-hydroxypyridazine (25.0 g, 0.151 mol) was dissolved in piperidine (120 mol) and heated to reflux for 24 hours. After cooling, the precipitated crystals were filtered to give white crystals of 3,5-dipiperidino-3-hydroxypyridazine (30.3 g, yield 75%).
    [59] 1 H-NMR (DMSO-d 6 , TMS, ppm)
    [60] δ: 1.56~1.78 (m, 12H, : piperidin dinhwan -N-CH 2 - CH 2 -CH 2 -CH 2 -CH 2 -N- × 2),
    [61] 3.16 (t, 4H, J = 5.2 ': piperidine ring -CH 2 -N-CH 2- ),
    [62] 3.26 (t, 4H, J = 5.2 ': piperidine ring -CH 2 -N-CH 2- ),
    [63] 7.57 (s, 1H: pyridazine ring H-6, 10.32 (s, 1H, OH),
    [64] MS spectrum: MW = 262 (C 14 H 22 N 4 O = 262.36)
    [65] Preparation Example 2 6-morpholino-3-hydroxypyridazine
    [66] 6-chloro-3-hydroxypyridazine (25.0 g, 0.191 mol) was dissolved in morpholine (120 mol) and heated to reflux for 24 hours. After cooling, the precipitated crystals were filtered to give white crystals (25.8 g, 74% yield) of 6-morpholino-3-hydroxypyridazine.
    [67] 1 H-NMR (DMSO-d 6 , TMS, ppm)
    [68] δ: 3.15 (t, 4H, J = 4.8 Hz: -CH 2 -N-CH 2- ),
    [69] 3.67 (t, 4H, J = 4.8 Hz: -CH 2 -O-CH 2- ),
    [70] 6.79 (d, 1H, J = 10.4 ㎐: pyridazine ring H-4 or H-5),
    [71] 7.49 (d, 1H, J = 10.4 ㎐: pyridazine ring H-4 or H-5),
    [72] 12.13 (s, 1H: OH)
    [73] MS spectrum: MW = 181 (C 8 H 11 N 3 O 2 = 181.19)
    [74] Preparation Example 3 3,6-dimorpholinopyridazine
    [75] 3,6-dichloropyridazine (25.0 g, 0.168 mol) was dissolved in morpholine (120 mol) and heated to reflux for 24 hours. After cooling, the precipitated crystals were filtered to give white crystals of 3,6-dimorpholinopyridazine (33.7 g, yield 80%).
    [76] 1 H-NMR (DMSO-d 6 , TMS, ppm)
    [77] δ: 3.42 (t, 8H, J = 4.8 Hz: -CH 2 -N-CH 2- ),
    [78] 3.80 (t, 8H, J = 4.8 Hz: -CH 2 -O-CH 2- ),
    [79] 6.92 (s, 2H, pyridazine ring H-4 and H-5),
    [80] MS spectrum: MW = 250 (C 12 H 18 N 4 O 2 = 250.30)
    [81] Next, the test regarding the ultraviolet absorbing ability of the pyridazine derivative of this invention is shown.
    [82] Test Example 1 Absorbance
    [83] 4,5-Dipiperidino-3-hydroxypyridazine, 3-hydroxy-4-piperidinopyridazine, 3-hydroxy-5-piperidinopyridazine, 3-hydroxy-4-morpholino Pyridazine, 3-hydroxy-5-morpholinopyridazine, 5-bis (2-hydroxyethyl) amino-3-hydroxypyridazine, 3-hydroxy-6-morpholinopyridazine, 3,6- The ultraviolet absorption spectrum (solvent: water, concentration 10ppm, optical path length 1cm) of bis (2-hydroxyethylamino) pyridazine and 3,6-dimorpholinopyridazine was spectrophotometer (Ubest-55 from Nippon Bunko Corp.) Was measured. The results are shown in FIGS. 1 to 9.
    [84] 1 to 9, the pyridazine derivative of the present invention can strongly absorb the ultraviolet rays of 290 nm to 400 nm reaching the surface over most of the wavelength range, and in the visible region on the longer wavelength side than 400 nm Since it shows little absorption, it can be said that transparency is excellent.
    [85] Test Example 2 Anti-UV Effect
    [86] (i) Test method
    [87] Practical tests were conducted at the following beaches. Samples were applied in equal amounts to the left and right halves of the back of the panel. The degree of sun tanning after direct sunlight exposure was evaluated according to the following criteria. In addition, it was performed by ten people in one group.
    [88] (Criteria)
    [89] Significant effect: No or almost sunburn symptoms were identified.
    [90] In effect: The sunburn was lightly observed.
    [91] No effect: strong sunburn symptoms were identified.
    [92] (Judgment)
    [93] ◎: 80% or more of test subjects with distinct effects or effects
    [94] ○: 50% or more but less than 80% of the test subjects have a distinct effect or effect
    [95] (Triangle | delta): 30% or more and less than 50% of the test subjects who have a distinct effect or effect
    [96] ×: less than 30% of test subjects with distinct effects or effects
    [97] (ii) preparation of samples;
    [98] (a) lotion
    [99] (Alcoholic)
    [100] 95% ethanol 25.0 mass%
    [101] POE (25) Cured Castor Oil 2.0
    [102] Ultraviolet absorber (listed in Table 1) 0-20
    [103] Preservative
    [104] Fragrance
    [105] (Awards)
    [106] Glycerin 5.0
    [107] Sodium hexametaphosphate
    [108] Ion-exchanged water remaining
    [109] (quite)
    [110] An aqueous phase and an alcohol phase were each prepared, and then mixed.
    [111] (b) cream
    [112] Stearyl alcohol 7.0% by mass
    [113] Stearic Acid 2.0
    [114] Hydrogenated lanolin 2.0
    [115] Squalene 5.0
    [116] 2-octyldodecyl alcohol 6.0
    [117] POE (25) cetyl ether 3.0
    [118] Glycerin Monostearic Acid Ester 2.0
    [119] Propylene Glycol 5.0
    [120] UV absorber (described in Table 2) 0 to 20
    [121] Fragrance
    [122] Sodium hydrogen sulfite 0.03
    [123] Ethylparaben 0.3
    [124] Ion Exchange Water Residue
    [125] (quite)
    [126] Propylene glycol was added and dissolved in ion-exchanged water, and it heated and maintained at 70 degreeC (water phase). The other components were mixed and melted and kept at 70 ° C (oil phase). The oil phase was added to the aqueous phase and pre-emulsified to emulsify it homogeneously with a homomixer, and it cooled to 30 degreeC, mixing well.
    [127] (iii) results
    [128] The results for (a) lotion are shown in Table 1 and the results for (b) cream are shown in Table 2.
    [129] (a) lotion UV absorbersCompounding amountUV protection effect 4,5-Dipyrrolidino-3-hydroxypyridazine2010510.010.0010.0005◎◎◎◎◎ ○ △ 3-hydroxy-5-morpholinopyridazine2010510.010.0010.0005◎◎◎◎◎ ○ △ 3-hydroxy-4-piperidinopyridazine2010510.010.0010.0005◎◎◎◎◎ ○ △ No mix-×
    [130] (b) cream UV absorbersCompounding amountUV protection effect 4,5-Dipyrrolidino-3-hydroxypyridazine2010510.010.0010.0005◎◎◎◎◎ ○ △ 3-hydroxy-5-morpholinopyridazine2010510.010.0010.0005◎◎◎◎◎ ○ △ 3-hydroxy-4-piperidinopyridazine2010510.010.0010.0005◎◎◎◎◎ ○ △ No mix-×
    [131] As is apparent from Table 1 and Table 2, the skin external preparation which mix | blended the pyridazine derivative of this invention as an ultraviolet absorber had the outstanding ultraviolet protection effect. Moreover, it turns out that 0.001-20 mass% is preferable for the compounding quantity of the pyridazine derivative of this invention and / or its salt. In addition, blending more than 20 mass% is difficult in formulation.
    [132] As mentioned above, the pyridazine derivative which concerns on this invention has the outstanding water absorption ability over a wide range of ultraviolet range. Therefore, in order to investigate whether or not the pyridazine derivative of the present invention can be blended into an external preparation for skin as an ultraviolet absorber, further investigation was conducted on the effects of skin irritation, light stability and inorganic powder.
    [133] Test Example 3 Skin irritation test
    [134] It carried out using the sample similar to the test example 2 (the compounding quantity of a ultraviolet absorber is 10 mass%).
    [135] (i) Continuous use test
    [136] Continuous use test by healthy test subjects was carried out in 20 groups of 1 group. Each sample was apply | coated twice a day for 4 weeks on an appropriate amount face, and it judged by the following criteria.
    [137] (Criteria)
    [138] Degree of skin reaction
    [139] No symptoms (negative) 0
    [140] Minor (similar voice) 1
    [141] Hardness 2
    [142] Moderate (medium training) 3
    [143] Altitude 4
    [144] (Judgment)
    [145] The average score was obtained and determined based on the following criteria.
    [146] ◎: Average score is 0
    [147] ○: Average score is greater than 0 and less than 1
    [148] △: average score is more than 1 and less than 2
    [149] ×: Average score is 2 or more
    [150] (result)
    [151] The results are shown in the table below.
    [152] UV absorbersFormulationJudgment 4,5-Dipiperidino-3-hydroxypyridazineLotion cream◎◎ 3-hydroxy-5-morpholinopyridazineLotion cream◎◎ 3-hydroxy-4-piperidinopyridazineLotion cream◎◎ No mixLotion cream◎◎
    [153] (ii) batch testing
    [154] Twenty-four-hour occlusion placement tests were performed with 20 patients in a group using a pin chamber at the forearm flexion of healthy male and female volunteers.
    [155] (Criteria)
    [156] Score of skin response
    [157] No reaction (negative) 0
    [158] Mild erythema (similar voice) 1
    [159] Erythema (weak positive) 2
    [160] Erythema + edema (moderately benign) 3
    [161] Erythema + Edema + Papules (Gangyangseong) 4
    [162] Algebra (Strength Training) 5
    [163] (Judgment)
    [164] The average score was obtained and determined based on the following criteria.
    [165] ◎: Average score is 0
    [166] ○: Average score is greater than 0 and less than 1
    [167] △: average score is more than 1 and less than 2
    [168] ×: Average score is 2 or more
    [169] (result)
    [170] The results are shown in the table below.
    [171] UV absorbersFormulationJudgment 4,5-Dipiperidino-3-hydroxypyridazineLotion cream◎◎ 3-hydroxy-5-morpholinopyridazineLotion cream◎◎ 3-hydroxy-4-piperidinopyridazineLotion cream◎◎ No mixLotion cream◎◎
    [172] As apparent from Tables 3 and 4, it was confirmed that the external preparation for skin containing the ultraviolet absorbent of the present invention had no skin irritation at all in the continuous use test and the batch test, and was excellent in safety.
    [173] Test Example 4 Light Stability Test
    [174] After exposure of the pyridazine derivative solution of the present invention to sunlight for two weeks (80 MJ of solar radiation dose), the change in residual ratio and appearance was examined and the ultraviolet absorption spectrum (solvent: water, concentration 10 ppm, optical path length 1 cm) was examined. Measured with a spectrophotometer, the area of 290 nm to 400 nm of the ultraviolet absorption spectrum was integrated to obtain an area value, and compared with the previous daylight width.
    [175] (Judgment)
    [176] The change of the residual ratio and the area value of the ultraviolet absorption spectrum was determined based on the following criteria.
    [177] ◎: 95% or more before the sun exposure
    [178] ○: 90% or more and less than 95% before daylight exposure
    [179] △: 70% or more and less than 90% before daylight exposure
    [180] ×: less than 70% before daylight exposure
    [181] (result)
    [182] The results are shown in the table below.
    [183] UV absorbersSurvival rateChange in Area Value of Ultraviolet Absorption Spectrum 4,5-Dipiperidino-3-hydroxypyridazine◎◎ 3-hydroxy-5-morpholinopyridazine◎◎ 3-hydroxy-4-piperidinopyridazine◎◎
    [184] As can be seen from Table 5, the pyridazine derivative of the present invention was not decomposed by a long period of direct sunlight exposure, but showed a very high residual rate. In addition, there was no change in the shape and area value of the ultraviolet absorption spectrum, and no coloring or precipitation was observed in the appearance.
    [185] Test Example 5 Stability Test in Combination with Inorganic Powder Sunscreen
    [186] In combination with an inorganic powder sunscreen, which is formulated as a sunscreen cream and stored at 50 ° C. for 2 months and observed discoloration by visual confirmation, it is well formulated as a skin external preparation for the purpose of UV protection. The stability of was examined.
    [187] (Prescription)
    [188] Sunscreen cream
    [189] (1) 1.0 mass% of ethyl cellulose
    [190] (2) Ethanol 5.0
    [191] (3) 2-ethylhexyl zucchini 24.0
    [192] (4) Titanium dioxide 1.0
    [193] (5) Porous Anhydrous Silicate Powder 1.0
    [194] (6) spherical nylon powder 1.0
    [195] (7) talc 1.0
    [196] (8) Serisite 1.0
    [197] (9) Boron Nitride 1.0
    [198] (10) Silicon Treatment Mica 1.0
    [199] (11) UV absorber (listed in Table 6) 10.0
    [200] (12) Carboxymethyl cellulose 1.0
    [201] (13) Ion exchange water residual
    [202] (14) appropriate amount of preservative
    [203] (15) appropriate amount of perfume
    [204] (quite)
    [205] After adding (2) to (1) and fully swelling, (3)-(11) was added and heat-mixed, and it fully disperse | distributed and melt | dissolved. The dispersion was maintained at 70 ° C., and the solution containing (12) to (15) was gradually added to emulsify with a homomixer, and then cooled to 30 ° C. while mixing well to obtain sunscreen cream.
    [206] (result)
    [207] The results are shown in the table below.
    [208] UV absorbersdiscoloration 4,5-Dipiperidino-3-hydroxypyridazinenone 3-hydroxy-5-morpholinopyridazinenone 3-hydroxy-4-piperidinopyridazinenone
    [209] As apparent from Table 6, the pyridazine derivative of the present invention was not discolored even when using an inorganic powder.
    [210] As described above, the pyridazine derivative according to the present invention has no skin irritation, is excellent in light stability, and does not cause discoloration even when used in combination with inorganic powder. Therefore, the pyridazine derivative of the present invention is very useful as an ultraviolet absorbent that can be blended into the external preparation for skin.
    [211] Next, the effect of the pyridazine derivative of the present invention as a light stabilizer was investigated.
    [212] First, the light stabilization effect and the appearance change of the composition for each pigment were investigated by the following evaluation prescription.
    [213] Evaluation Examples of Experimental Examples 6-91 Pigment Stabilization Effect
    [214] Raw material name Compounding quantity (mass%)
    [215] Ion Exchange Water to 100
    [216] Blue modified alcohol 5
    [217] Glycerin 5
    [218] Dipropylene glycol 5
    [219] Polyoxyethylene hardened castor oil 1
    [220] Methylparaben 0.2
    [221] Heritage 0.006
    [222] Sodium Lactate 0.2
    [223] Light Stabilizers (Listed in Tables 7-9) Listed in Tables 7-9
    [224] Dye (described in Tables 7 to 9) Table 7 to Table 9
    [225] 100 total
    [226] Each test sample was adjusted to observe changes in appearance (view judgment) and color difference (ΔE) of the samples before and after daylight exposure (80 MJ).
    [227] The color difference was measured by a Lab coordinate system in a spectrophotometer and calculated based on the color before daylight width. That is, the following equation was obtained a color difference (ΔE) from the measured value (L 1, a 1, b 1) before sunlight exposure.
    [228] ΔE = {(L 2 -L 1 ) 2 + (a 2 -a 1 ) 2 + (b 2 -b 1 ) 2 } 1/2
    [229] The results are shown in Tables 7 to 9.
    [230]
    [231]
    [232]
    [233] From the results of Tables 7 to 9, it can be seen that the color difference (ΔE) in the pyridazine derivative of the present invention is noticeably smaller than other light stabilizers. Moreover, it turns out that there is little change of the external appearance of a composition. Therefore, it can be seen that the pyridazine derivatives of the present invention have excellent photostabilization effect on pigments.
    [234] Next, the photostabilization effect on each perfume was investigated by the following evaluation prescription.
    [235] Test Examples 92-181 Prescription of fragrance stabilization effect
    [236] Raw material name Compounding quantity (mass%)
    [237] Ion Exchange Water to 100
    [238] Blue modified alcohol 5
    [239] Glycerin 5
    [240] Dipropylene glycol 5
    [241] Polyoxyethylene hardened castor oil 1
    [242] Methylparaben 0.2
    [243] Heritage 0.006
    [244] Sodium Lactate 0.2
    [245] Light Stabilizers (Listed in Tables 10-12) Listed in Tables 10-12
    [246] Fragrance (listed in Tables 10 to 12) Listed in Tables 10 to 12
    [247] 100 total
    [248] Each test sample was prepared, and the fragrance change observation (determination at the time of steering) of the sample before and after the sun exposure (80 MJ) was performed. The results are shown in Tables 10-12.
    [249]
    [250]
    [251]
    [252] From the results in Tables 10 to 12, it can be seen that the fragrance change in the pyridazine derivative of the present invention is noticeably smaller than other light stabilizers. Therefore, it can be seen that the pyridazine derivative of the present invention has an excellent photo stabilizing effect on the perfume.
    [253] Next, the photostabilization effect on the drug and the appearance change of the composition were examined by the following evaluation prescription.
    [254] Test Examples 182 to 211 Prescription of drug stabilization effect
    [255] Raw material name Compounding quantity (mass%)
    [256] Ion Exchange Water to 100
    [257] Blue modified alcohol 5
    [258] Glycerin 5
    [259] Dipropylene glycol 5
    [260] Polyoxyethylene hardened castor oil 1
    [261] Methylparaben 0.2
    [262] Heritage 0.006
    [263] Sodium Lactate 0.2
    [264] Light Stabilizers (listed in Table 13) Table 13
    [265] Drug (we list in table 13) We list in table 13
    [266] 100 total
    [267] Each test sample was prepared, and the residual ratio was measured by the observation of the appearance change (visual judgment) and the liquid chromatography of the sample before and after the sun exposure (80 MJ). The results are shown in Table 13.
    [268]
    [269] From the results in Table 13, it can be seen that the residual ratio of the drug in the pyridazine derivative of the present invention is remarkably high compared with other light stabilizers. Moreover, it turns out that there is little change of the external appearance of a composition. Therefore, it can be seen that the pyridazine derivative of the present invention has an excellent photostabilizing effect on the drug.
    [270] The present inventors have attempted to improve the light stabilizing effect by combining a metal ion sequestering agent with the light stabilizer.
    [271] First, the photostabilization effect on the pigment and the appearance change of the composition were examined by the following evaluation prescription.
    [272] Test Example 212-275 Evaluation of pigment stabilization effect (Metal ion sequestrant formulation)
    [273] Raw material name Compounding quantity (mass%)
    [274] Ion Exchange Water to 100
    [275] Blue modified alcohol 5
    [276] Glycerin 5
    [277] Dipropylene glycol 5
    [278] Polyoxyethylene hardened castor oil 1
    [279] Methylparaben 0.2
    [280] Heritage 0.006
    [281] Sodium Lactate 0.2
    [282] Metal ion sequestrants (described in Tables 14 to 15) Listed in Tables 14 to 15
    [283] Light stabilizer (as described in Tables 14 to 15) Listed in Tables 14 to 15
    [284] Dye (described in Tables 14 to 15) Listed in Tables 14 to 15
    [285] 100 total
    [286] Each test sample was prepared, and the appearance change observation (visual judgment) and the color difference ((DELTA) E) of the sample before and after daylight exposure (80 MJ) were performed.
    [287] The color difference was measured by a Lab coordinate system in a spectrophotometer and calculated based on the color before daylight width. That is, the following equation was obtained a color difference (ΔE) from the measured value (L 1, a 1, b 1) before sunlight exposure.
    [288] ΔE = {(L 2 -L 1 ) 2 + (a 2 -a 1 ) 2 + (b 2 -b 1 ) 2 } 1/2
    [289] The results are shown in Tables 14 to 15.
    [290]
    [291]
    [292] The results of Tables 14 to 15 show that the color difference ΔE in the case where the pyridazine derivative of the present invention is combined with the metal ion sequestering agent is small compared with the case where no metal ion sequestering agent is combined. Moreover, it turns out that the change of the external appearance of a composition is also smaller. Therefore, it can be seen that the pyridazine derivative of the present invention has a better photostabilizing effect on the dye when the metal ion sequestrant is combined.
    [293] Further, considering that the metal ion sequestrant alone has almost no photostabilizing effect, it can be said that the combination of the pyridazine derivative of the present invention and the metal ion sequestrant have a synergistic effect on the photostabilization effect.
    [294] Next, the light stabilization effect on each perfume in the case of combining the metal ion blocking agent was investigated by the following evaluation prescription.
    [295] Experimental Examples 276 to 371 Evaluation of fragrance stabilizing effect (Metal ion sequestrant formulation)
    [296] Raw material name Compounding quantity (mass%)
    [297] Ion Exchange Water to 100
    [298] Blue modified alcohol 5
    [299] Glycerin 5
    [300] Dipropylene glycol 5
    [301] Polyoxyethylene hardened castor oil 1
    [302] Methylparaben 0.2
    [303] Heritage 0.006
    [304] Sodium Lactate 0.2
    [305] Metal ion sequestrants (described in Tables 16-18) listed in Tables 16-18
    [306] Light stabilizer (as described in Tables 16 to 18) Listed in Tables 16 to 18
    [307] Fragrance (listed in Tables 6-8) 0.03
    [308] 100 total
    [309] Each test sample was prepared, and the fragrance change observation (determination at the time of steering) of the sample before and after the sun exposure (80 MJ) was performed. The results are shown in Tables 16-18.
    [310]
    [311]
    [312]
    [313] From the results of Tables 16 to 18, it can be seen that the change in the scent when the metal ion sequestrant is combined with the pyridazine derivative of the present invention is small compared with the case where no metal ion sequestrant is combined. Therefore, it can be seen that the pyridazine derivative of the present invention has a better light stabilizing effect on the perfume when the metal ion sequestrant is combined.
    [314] Further, considering that the metal ion sequestrant alone has almost no photostabilizing effect, it can be said that the combination of the pyridazine derivative of the present invention and the metal ion sequestrant have a synergistic effect on the photostabilization effect.
    [315] Next, the photostabilization effect and the appearance change of the composition of the respective medicaments when the metal ion sequestrant was combined were examined by the following evaluation prescription.
    [316] Experimental Examples 372 to 391 Evaluation of Pharmaceutical Stabilization Effect (Metal Ion Blocker Formulation)
    [317] Raw material name Compounding quantity (mass%)
    [318] Ion Exchange Water to 100
    [319] Blue modified alcohol 5
    [320] Glycerin 5
    [321] Dipropylene glycol 5
    [322] Polyoxyethylene hardened castor oil 1
    [323] Methylparaben 0.2
    [324] Heritage 0.006
    [325] Sodium Lactate 0.2
    [326] Metal ion sequestrants (listed in Table 19) Table 19
    [327] Light Stabilizers (listed in Table 19) Table 19
    [328] Drug (we list in table 19) We list in table 19
    [329] 100 total
    [330] Each test sample was prepared, and the residual ratio was measured by the observation of the appearance change (visual judgment) and the liquid chromatography of the sample before and after the sun exposure (80 MJ). The results are shown in Table 19.
    [331]
    [332] From the result of Table 19, it turns out that the residual ratio of the chemical | medical agent in the case where the pyridazine derivative of this invention is combined with a metal ion blocking agent is high compared with the case where no metal ion blocking agent is combined. Moreover, it turns out that the change of the external appearance of a composition is also smaller. Therefore, it can be seen that the pyridazine derivative of the present invention has a better photostabilizing effect on the drug when the metal ion sequestrant is combined.
    [333] Further, considering that the metal ion sequestrant alone has almost no photostabilizing effect, it can be said that the combination of the pyridazine derivative of the present invention and the metal ion sequestrant have a synergistic effect on the photostabilization effect.
    [334] (Example)
    [335] Hereinafter, although the Example of the external skin preparation which concerns on this invention is illustrated, this invention is not limited to these. In addition, all compounding quantities are represented by mass%.
    [336] Example 1 lotion
    [337] (Alcoholic)
    [338] Ethanol 10.0
    [339] Oleyl alcohol 0.1
    [340] POE (20) sorbitan monolauric acid ester 0.5
    [341] POE (15) lauryl ether 0.5
    [342] 4,5-diperidino-3-hydroxypyridazine 5.0
    [343] Preservative
    [344] Fragrance
    [345] (Awards)
    [346] 1,3-butylene glycol 6.0
    [347] Glycerin 4.0
    [348] Ion Exchange Water Residue
    [349] (quite)
    [350] Aqueous phase and alcohol phase were prepared, respectively, and mixed.
    [351] Example 2 lotion
    [352] (Alcoholic)
    [353] Ethanol 10.0
    [354] POE (20) oleyl ether 0.5
    [355] Preservative
    [356] Fragrance
    [357] (Awards)
    [358] Dipropylene Glycol 6.0
    [359] Sorbit 4.0
    [360] PEG1500 5.0
    [361] 4,5-Dipiperidino-3-hydroxypyridazine Hydrochloride 20.0
    [362] Methylcellulose 0.2
    [363] Coins Seed 0.1
    [364] Ion Exchange Water Residue
    [365] (quite)
    [366] Methyl cellulose and quineseed were mixed and stirred in a part of ion-exchanged water to prepare a viscous liquid. The remainder of ion-exchanged water and the other aqueous phase components were mixed and dissolved, and the said viscous liquid was added to this, and the uniform water phase was obtained. The alcohol phase was prepared, then added to the aqueous phase and mixed.
    [367] Example 3 Cream
    [368] Stearic Acid 5.0
    [369] Stearyl Alcohol 4.0
    [370] Isopropyl myristate 18.0
    [371] Glycerine Monostearic Acid Ester 3.0
    [372] Propylene Glycol 10.0
    [373] 3-hydroxy-5-morpholinopyridazine 20.0
    [374] Potassium Hydroxide 0.2
    [375] Sodium hydrogen sulfite 0.01
    [376] Preservative
    [377] Fragrance
    [378] Ion Exchange Water Residue
    [379] (quite)
    [380] Propylene glycol and potassium hydroxide were added and dissolved in ion-exchanged water, and it heated and maintained at 70 degreeC (water phase). The other components were mixed and melted and kept at 70 ° C (oil phase). The oil phase was gradually added to the aqueous phase, preemulsified, and uniformly emulsified with a homomixer, and then cooled to 30 ° C while mixing well.
    [381] Example 4 Cream
    [382] Stearic Acid 6.0
    [383] Sorbitan monostearic acid ester 2.0
    [384] POE (20) sorbitan monostearic acid ester 1.5
    [385] Propylene Glycol 10.0
    [386] 3-hydroxy-5-piperidinopyridazine 1.0
    [387] Glycerin Trioctanoate 10.0
    [388] Squalane 5.0
    [389] Sodium hydrogen sulfite 0.01
    [390] Ethylparaben 0.3
    [391] Fragrance
    [392] Ion Exchange Water Residue
    [393] (quite)
    [394] Propylene glycol and 3-hydroxy-5-piperidinopyridazine were added and dissolved in ion-exchanged water, and heated and maintained at 70 ° C (aqueous phase). The other components were mixed and melted and kept at 70 ° C (oil phase). The oil phase was gradually added to the aqueous phase, preemulsified and uniformly emulsified with a homomixer, and then cooled to 30 ° C while mixing well.
    [395] Example 5 Latex
    [396] Stearic Acid 2.5
    [397] Cetyl Alcohol 1.5
    [398] Vaseline 5.0
    [399] Liquid Paraffin 10.0
    [400] POE (10) monoolefinic acid ester 2.0
    [401] PEG1500 3.0
    [402] Triethanolamine 1.0
    [403] 3-hydroxy-6-morpholinopyridazine 10.0
    [404] Sodium hydrogen sulfite 0.01
    [405] Ethylparaben 0.3
    [406] Carboxy vinyl polymer 0.05
    [407] Fragrance
    [408] Ion Exchange Water Residue
    [409] (quite)
    [410] The carboxyvinyl polymer was dissolved in a small amount of ion exchanged water (Phase A). PEG1500, 3-hydroxy-6-morpholinopyridazine, and triethanolamine were added to the remainder of the ion-exchanged water, and the mixture was heated and maintained at 70 ° C (water phase). The other components were mixed and melted and kept at 70 ° C (oil phase). The oil phase was gradually added to the aqueous phase to preemulsify. The A phase was added to emulsify uniformly with a homomixer, and then cooled to 30 ° C while mixing well.
    [411] Example 6 Gel
    [412] 95% Ethanol 10.0
    [413] Dipropylene Glycol 15.0
    [414] POE (50) oleyl ether 2.0
    [415] Carboxy Vinyl Polymer 1.0
    [416] Sodium hydroxide 0.15
    [417] 3,6-dimorpholinopyridazine 2.0
    [418] Methylparaben 0.2
    [419] Fragrance
    [420] Ion Exchange Water Residue
    [421] (quite)
    [422] The carboxyvinyl polymer was uniformly dissolved in ion exchanged water (phase A). 3,6-dimorpholinopyridazine and POE (50) oleyl ether were dissolved in 95% ethanol and added to phase A. After addition of components other than sodium hydroxide, sodium hydroxide was added to neutralize and thicken.
    [423] Example 7 Serum
    [424] (A phase)
    [425] 95% Ethanol 10.0
    [426] POE (20) octyldodecanol 1.0
    [427] Methylparaben 0.15
    [428] Pantothenylethyl Ether 0.1
    [429] (B phase)
    [430] Sodium Hydroxide 0.1
    [431] (C phase)
    [432] Glycerin 5.0
    [433] Dipropylene Glycol 10.0
    [434] Sodium hydrogen sulfite 0.03
    [435] Carboxy Vinyl Polymer 0.2
    [436] 3-hydroxy-4-piperidinopyridazine 0.1
    [437] Ion Exchange Water Residue
    [438] (quite)
    [439] A phase and C phase were melt | dissolved uniformly, respectively, and solubilized by adding A phase to C phase. Then, phase B was added and mixed.
    [440] Example 8 Pack
    [441] (A phase)
    [442] Dipropylene Glycol 5.0
    [443] POE (60) Cured Castor Oil 5.0
    [444] (B phase)
    [445] Olive oil 5.0
    [446] Tocopherol Acetate 0.2
    [447] Ethylparaben 0.2
    [448] Spices 0.2
    [449] (C phase)
    [450] 5-bis (2-hydroxyethyl) amino-3-hydroxypyridazine 3.0
    [451] Sodium hydrogen sulfite 0.03
    [452] Polyvinyl alcohol (degree of soap 90, degree of polymerization 2000) 13.0
    [453] Ethanol 7.0
    [454] Ion Exchange Water Residue
    [455] (quite)
    [456] A phase, B phase, and C phase were melt | dissolved uniformly, respectively, and B phase was added and solubilized. This was then added to C and mixed.
    [457] All the said Comparative Examples 1-7 had the outstanding ultraviolet protection effect. Moreover, in Examples 1-8, skin trouble was not confirmed at all.
    [458] Example 9 Latex
    [459] (Charged)
    [460] Stearyl Alcohol 1.5
    [461] Squalene 2.0
    [462] Vaseline 2.5
    [463] Deodorant Liquid Lanolin 1.5
    [464] Crude colostrum 2.0
    [465] Myristic Acid Isopropyl 5.0
    [466] Glycerin Monooleate 2.0
    [467] POE (60) Cured Castor Oil 2.0
    [468] Tocopherol Acetate 0.05
    [469] Ethylparabine 0.2
    [470] Butylparabine 0.1
    [471] Fragrance
    [472] (Awards)
    [473] 3,6-bis (2-hydroxyethylamino) pyridazine 1.0
    [474] 4,5-Dipiperidino-3-hydroxypyridazine 1.0
    [475] Sodium hydrogen sulfite 0.01
    [476] Glycerin 5.0
    [477] Sodium Hyaluronate 0.01
    [478] Carboxy Vinyl Polymer 0.2
    [479] Potassium Hydroxide 0.2
    [480] Ion-exchanged water remaining
    [481] (quite)
    [482] The oil phase and the aqueous phase were each dissolved at 70 ° C, the oil phase was mixed with the aqueous phase, emulsified with an emulsifier, and then cooled to 30 ° C in a heat exchanger.
    [483] The emulsion of Example 9 also has an excellent UV protection effect, no skin trouble was confirmed.
    [484] Example 10 Solid Powder Foundation
    [485] (1) talc 15.0
    [486] (2) Serisite 10.0
    [487] (3) spherical nylon powder 10.0
    [488] (4) Porous Anhydrous Silicate Powder 15.0
    [489] (5) boron nitride 5.0
    [490] (6) Titanium dioxide 5.0
    [491] (7) Oxygen 3.0
    [492] (8) zinc stearate 5.0
    [493] (9) 3-hydroxy-5-morpholinopyridazine 5.0
    [494] (10) Fluid Paraffin Residue
    [495] (11) glycerin triisooctanoate 15.0
    [496] (12) Secruole sorbate 1.5
    [497] (13) Preservative
    [498] (14) appropriate amount of perfume
    [499] (quite)
    [500] What mixed each component of (1)-(8), was mixed with the components of (9)-(14), stirred and mixed, it shape | molded in the container, and the solid foundation was obtained.
    [501] Example 11 Oil-in-water emulsion foundation
    [502] (1) spherical nylon 10.0
    [503] (2) Porous Anhydrous Silicate Powder 8.0
    [504] (3) mica titanium 2.0
    [505] (4) silicon treated Sericite 2.0
    [506] (5) silicon treated mica 12.0
    [507] (6) silicon treated titanium dioxide 5.0
    [508] (7) siliconized iron oxide 2.0
    [509] (8) Ion exchange water residual
    [510] (9) 3-hydroxy-5-piperidinopyridazine 3.0
    [511] (10) Decamethylcyclopentanesiloxane 18.0
    [512] (11) Dimethylpolysiloxane 5.0
    [513] (12) Squalene 1.0
    [514] (13) polyoxyethylene modified dimethylpolysiloxane 2.0
    [515] (14) appropriate amount of preservative
    [516] (15) appropriate amount of perfume
    [517] (quite)
    [518] The mixed and pulverized (1) to (7) was added to and dispersed in the mixture of the components (9) to (15) that were uniformly dissolved. (8) was added to this dispersion, emulsified, and it filled into the container, and obtained the water-in-oil emulsion foundation.
    [519] Example 12 Percent
    [520] (1) talc residue
    [521] (2) Serisite 10.0
    [522] (3) spherical nylon powder 10.0
    [523] (4) boron nitride 5.0
    [524] (5) iron oxide 3.0
    [525] (6) magnesium carbonate 5.0
    [526] (7) squalene 3.0
    [527] (8) glycerol triisooctanoate 2.0
    [528] (9) Secruole sorbate 2.0
    [529] (10) 3-hydroxy-6-morpholinopyridazine 0.1
    [530] (11) preservative
    [531] (12) appropriate amount of perfume
    [532] (quite)
    [533] What mixed each component of (1)-(6) and mixed and grind | mixed each component of (7)-(12) was added and stirred and mixed, and the powder was obtained.
    [534] Example 13 Eye Shadow
    [535] (1) talc residue
    [536] (2) Mica 15.0
    [537] (3) spherical nylon powder 10.0
    [538] (4) boron nitride 5.0
    [539] (5) iron oxide 3.0
    [540] (6) Titanium oxide coating mica 5.0
    [541] (7) squalene 3.0
    [542] (8) triglyceride octanoate 2.0
    [543] (9) Secruole sorbate 2.0
    [544] (10) 3-hydroxy-4-piperidinopyridazine 2.0
    [545] (11) preservative
    [546] (12) appropriate amount of perfume
    [547] (quite)
    [548] What mix | blended and mixed each component of (1)-(6) with the thing which mixed each component of (7)-(12) was added and stirred and mixed, and the eye shadow was obtained.
    [549] Example 14 Lipstick
    [550] (1) untreated carnauba 0.5
    [551] (2) untreated Candy Lilla 5.0
    [552] (3) Selesin 10.0
    [553] (4) squalene residual
    [554] (5) Glycerin triisostearate 10.0
    [555] (6) glycerin diisostearate 20.0
    [556] (7) 3,6-dimorpholinopyridazine 1.0
    [557] (8) macadamia nut oil fatty acid cholesteryl 4.0
    [558] (9) synthetic sodium silicate-magnesium 0.5
    [559] (10) Hydrophobic silica 0.5
    [560] (11) ion exchange water 2.0
    [561] (12) A suitable amount of bonding
    [562] (13) Preservative
    [563] (14) appropriate amount of perfume
    [564] (quite)
    [565] (9) and (10) were disperse | distributed to (8) heated at 60 degreeC, (11) was added to this, and it fully stirred. It was added to (1)-(7) heated and melt | dissolved separately, it stirred sufficiently, dispersion and stirring were carried out by adding (12)-(14), and it shape | molded after that, and obtained the lipstick.
    [566] All of the makeup cosmetics of Examples 10 to 14 had excellent ultraviolet protection effect, and no skin trouble, discoloration with time or the like was observed.
    [567] Example 15 Hair Foam
    [568] (Prescription)
    [569] (1) Acrylic resin alkanolamine liquid (50%) 8.0
    [570] (2) Polyoxyethylene hardened castor oil appropriate amount
    [571] (3) floating paraffin 5.0
    [572] (4) glycerin 3.0
    [573] (5) appropriate amount of perfume
    [574] (6) appropriate amount of preservative
    [575] (7) Ethanol 15.0
    [576] (8) 5-bis (2-hydroxyethyl) amino-3-hydroxypyridazine 0.01
    [577] (9) Residual water of ion exchange water
    [578] (Charge prescription)
    [579] (1) Stock 90.0
    [580] (2) Liquefied petroleum gas 10.0
    [581] (quite)
    [582] Fluid paraffin is added to the melt of glycerin and polyoxyethylene hardened castor oil, and it is emulsified uniformly by a homomixer. It is added to a solution of other ingredients. Filling fills the can with the stock solution, and then fills the gas with the valve.
    [583] Example 16 Hair Liquid
    [584] (1) polyoxypropylene (40) butyl ether 20.0
    [585] (2) polyoxyethylene hardened castor oil 1.0
    [586] (3) Ethanol 50.0
    [587] (4) appropriate amount of perfume
    [588] (5) appropriate amount of preservative
    [589] (6) dyes
    [590] (7) 3,6-bis (2-hydroxyethylamine) pyridazine 2.0
    [591] (8) Residue of ion exchange water
    [592] (quite)
    [593] Polyoxypropylene (40) butyl ether, polyoxyethylene hardened castor oil, 3,6-bis (2-hydroxyethylamine) pyridazine, perfume, and preservative are dissolved in ethanol. Dissolve the dye in ion-exchanged water. An aqueous phase is added over ethanol and filtered with a filter paper or the like.
    [594] Example 17 Hairspray
    [595] (Prescription)
    [596] (1) acrylic resin alkanolamine liquid (50%) 7.0
    [597] (2) cetyl alcohol 0.1
    [598] (3) silicone oil 0.3
    [599] (4) Ethanol residue
    [600] (5) appropriate amount of perfume
    [601] (6) 4,5-dipiperidino-3-hydroxypyridazine 2.0
    [602] (7) ion exchange water 3.0
    [603] (Charge prescription)
    [604] (1) Stock 50.0
    [605] (2) Liquefied petroleum gas 50.0
    [606] (quite)
    [607] Add other ingredients to ethanol to dissolve and filter. Filling fills the can with the stock solution, and after the valve is mounted, the gas is filled.
    [608] Example 18 Hair Tonic
    [609] (1) 3-hydroxy-5-morpholinopyridazine 3.0
    [610] (2) Cured castor oil ethylene oxide (40 mol) adduct 2.0
    [611] (3) Ethanol 60.0
    [612] (4) appropriate amount of perfume
    [613] (5) Residual ion exchange water
    [614] (quite)
    [615] Cured castor oil ethylene oxide (40 mol) adduct and 3-hydroxy-5-morpholinopyridazine are dissolved in ethanol. The ethanol phase and the water phase are mixed and the fragrance is added.
    [616] The cosmetics for hair and scalp of Examples 15 to 18 all had excellent ultraviolet protection effects, and no scalp troubles or discoloration with time were observed.
    [617] The novel pyridazine derivative of the present invention is an ultraviolet absorbent, which has a very excellent ultraviolet absorbing ability to strongly absorb ultraviolet rays over a wide wavelength range, and also shows an excellent photostabilizing ability as a light stabilizer. In addition, the pyridazine derivatives have high safety and stability. Therefore, by mix | blending this, the ultraviolet-ray prevention effect was high and the stability was improved by the light stabilization effect. A skin external preparation with good safety is obtained.
    权利要求:
    Claims (13)
    [1" claim-type="Currently amended] A ultraviolet absorber characterized by the following pyridazine derivatives and / or salts thereof as an active ingredient.

    [Wherein, R 1 and R 4 are each independently a hydrogen atom, a hydroxyl group, a lower alkyl group, a lower alkoxy group, or a N (R 5 ) R 6 group [R 5 and R 6 are the same or different, and a hydrogen atom, a lower alkyl group, A lower hydroxyalkyl group or R 5 and R 6 together form an aziridinyl group, an azetidinyl group, a pyrrolidinyl group, a piperidino group, a hexahydroazinyl group, a heptamethylene imino group, an octamethylene imino group together with a nitrogen atom, mol Poly group, a thio mol Poly group, piperadinyl group, a 4-lower alkyl piperazinyl represents a heterocyclic group selected from the group consisting of radio carbonyl] represents a, R 2 and R 3 are each independently a hydrogen atom, a bromine atom, a chlorine An atom, a hydroxyl group, a lower alkyl group, a lower alkoxy group, or an N (R 7 ) R 8 group [R 7 and R 8 are the same or different and a hydrogen atom, a lower alkyl group, a lower hydroxyalkyl group or R 7 and R 8 together Aziridinyl group, azetidinyl with nitrogen atom Group consisting of a group, a pyrrolidinyl group, a piperidino group, a hexahydroazinyl group, a heptamethyleneimino group, an octamethylene imino group, a morpholino group, a thiomorpholino group, a piperadinyl group, and a 4-lower alkylpiperadinyl group Represents a heterocyclic group selected from " Provided that R 1 , R 2 , R 3 and R 4 are not hydrogen atoms at the same time, and R 2 and R 3 are not morpholino groups at the same time.] [2" claim-type="Currently amended] The ultraviolet absorber according to claim 1, wherein R 1 is a hydroxyl group.
    [3" claim-type="Currently amended] The ultraviolet absorber according to claim 1, wherein R 1 is a hydroxyl group and R 4 is a hydrogen atom.
    [4" claim-type="Currently amended] The compound of claim 1, wherein R 1 is a hydroxyl group, R 2 and R 3 are each independently N (R 7 ) R 8 groups [R 7 and R 8 are the same or different, a hydrogen atom, a lower alkyl group, a lower hydroxyalkyl group or R 7 and R 8 together form aziridinyl, azetidinyl, pyrrolidinyl, piperidino, hexahydroazinyl, heptamethyleneimino, octamethyleneimino, morpholino and thio A heterocyclic group selected from the group consisting of a morpholino group, a piperadinyl group and a 4-lower alkylpiperadinyl group] (wherein R 2 and R 3 are not at the same time a morpholino group), and R 4 is a hydrogen atom. A ultraviolet absorber characterized by the above-mentioned.
    [5" claim-type="Currently amended] The compound of claim 1, wherein R 1 is a hydroxyl group, R 2 and R 3 are each independently N (R 7 ) R 8 groups [R 7 and R 8 are the same or different, and a lower hydroxyalkyl group or R 7 and R 8 are Together represent a heterocyclic group selected from the group consisting of a pyrrolidinyl group, a piperidino group, a morpholino group, a piperadinyl group, and a 4-lower alkylpiperadinyl group together with a nitrogen atom] (wherein R 2 and R 3 are And at the same time, it is not a morpholino group), wherein R 4 is a hydrogen atom.
    [6" claim-type="Currently amended] An optical stabilizer comprising the pyridazine derivative according to any one of claims 1 to 5 and / or a salt thereof as an active ingredient.
    [7" claim-type="Currently amended] The ultraviolet absorbent as described in any one of Claims 1-5 is contained, The ultraviolet absorbent composition characterized by the above-mentioned.
    [8" claim-type="Currently amended] 7. The light stabilizer according to claim 6, further comprising a metal ion blocking agent.
    [9" claim-type="Currently amended] The light stabilizer composition of Claim 6 or 8 containing the light stabilizer.
    [10" claim-type="Currently amended] The external preparation for skin containing the ultraviolet absorber as described in any one of Claims 1-5.
    [11" claim-type="Currently amended] The skin external preparation containing the light stabilizer of Claim 6 or 8.
    [12" claim-type="Currently amended] The external preparation for skin according to claim 10, further comprising an inorganic powder.
    [13" claim-type="Currently amended] The skin external preparation according to any one of claims 10 to 12, wherein the compounded amount of the pyridazine derivative and / or salt thereof according to claim 1 is 0.001 to 20% by mass.
    类似技术:
    公开号 | 公开日 | 专利标题
    JP2017061496A|2017-03-30|Sunscreen composition containing color pigment
    CN100391431C|2008-06-04|Microfine pigment mixture and its application for preventing skin from tanning and making skin and hair passess glass
    JP5066097B2|2012-11-07|Use of penetrating dyes to protect human skin from browning and aging
    EP0688559B1|2001-06-20|Skin anti-ageing composition
    EP0433086B2|2000-03-01|Sunscreen compositions
    EP0821945B1|2003-03-05|Photoprotective composition in foam form containing water soluble ultraviolet filters and surface active agents
    US4603046A|1986-07-29|Improved sunscreen or sunblock composition
    US6171580B1|2001-01-09|Ultraviolet-screening zinc oxide excellent in transparency and composition containing the same
    EP1352638B1|2009-05-20|Cosmetics for alleviating skin irritation
    US5028417A|1991-07-02|Sunscreen compositions
    JP5270134B2|2013-08-21|Ultraviolet absorber water dispersion composition
    US5543136A|1996-08-06|Sunscreen emulsions
    ES2634638T3|2017-09-28|Use of troxerutin to deactivate fluorescence of disodium phenyldibenzimidazole tetrasulfonate
    TWI225793B|2005-01-01|Cosmetic composition
    US5552135A|1996-09-03|Sunscreens containing plant extracts
    US6008246A|1999-12-28|External preparation for skin containing a low-molecular-weight betaine
    JP3004206B2|2000-01-31|Composition for treating skin spots and / or aging and uses thereof
    US6274124B1|2001-08-14|Additive for improving the water resistance of cosmetic or dermatological formulations
    JP4401875B2|2010-01-20|Oil-in-water emulsion composition
    US8263045B2|2012-09-11|Sunless tanning composition and method of sunless tanning
    EP1430905B1|2007-11-14|Skin treatment composition
    US20010053348A1|2001-12-20|Method for testing sunscreens
    JP5994790B2|2016-09-21|Whitening cosmetics
    US6858200B2|2005-02-22|Sunscreen formulations
    US5053222A|1991-10-01|Hair cosmetic composition
    同族专利:
    公开号 | 公开日
    EP1266651A3|2003-01-08|
    DE60214470D1|2006-10-19|
    EP1266651B1|2006-09-06|
    JP4514992B2|2010-07-28|
    US6676932B2|2004-01-13|
    TWI247613B|2006-01-21|
    US20030198608A1|2003-10-23|
    JP2002371265A|2002-12-26|
    EP1266651A2|2002-12-18|
    DE60214470T2|2007-05-31|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    法律状态:
    2001-06-15|Priority to JP2001182640A
    2001-06-15|Priority to JPJP-P-2001-00182640
    2002-06-15|Application filed by 가부시키가이샤 시세이도
    2002-12-31|Publication of KR20020096931A
    优先权:
    申请号 | 申请日 | 专利标题
    JP2001182640A|JP4514992B2|2001-06-15|2001-06-15|Ultraviolet absorber, light stabilizer, and ultraviolet absorbing composition, light stabilizing composition and skin external preparation containing the same|
    JPJP-P-2001-00182640|2001-06-15|
    [返回顶部]